Jupiter Neurosciences (JUNS) Notes Payables (2023 - 2026)

Jupiter Neurosciences (JUNS) has reported Notes Payables for 4 consecutive years, with $1.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Notes Payables rose 943.81% year-over-year to $1.5 million in Q2 2026; TTM through Jun 2026 was $1.5 million, a 943.81% increase from a year earlier, with the FY2025 full-year figure at $5.3 million, up 3518.11% from the prior year.
• Notes Payables was $1.5 million for Q2 2026 at Jupiter Neurosciences, down from $5.3 million in the prior quarter.
• Over five years, Notes Payables peaked at $5.3 million in Q4 2025 and troughed at $146432.0 in Q4 2024.
• A 4-year average of $1.2 million and a median of $376609.5 in 2024 frame the typical range for Notes Payables.
• Across the five-year window, Notes Payables plunged 91.06% in 2024 and soared 3518.11% in 2025, its largest moves.
• Over 4 years, Notes Payables stood at $1.6 million in 2023, then sank by 91.06% to $146432.0 in 2024, then soared by 3518.11% to $5.3 million in 2025, then slumped by 71.15% to $1.5 million in 2026.
• The last three Notes Payables figures came in at $1.5 million (Q2 2026), $5.3 million (Q4 2025), and $146432.0 (Q3 2025), per Business Quant data.